BRIACELL THERAP (BCTX)
(Delayed Data from NSDQ)
$12.44 USD
-0.90 (-6.75%)
Updated Oct 29, 2025 04:00 PM ET
After-Market: $12.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, BRIACELL THERAP has a market cap of $9.04M, which represents its share price of $13.34 multiplied by its outstanding shares number of 0.68M. As a small-cap company, BCTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
BCTX 12.44 -0.90(-6.75%)
Will BCTX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BCTX based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for BCTX
Zacks.com featured highlights include Groupon, BriaCell Therapeutics and InnovAge Holding
Top 3 Earnings Acceleration Buys for November
BCTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About BRIACELL THERAP (BCTX) Rating Upgrade to Buy
BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?
Other News for BCTX
BCTX forms Bollinger Band Squeeze on October 28
Is BCTX set to breakout? Bollinger Band Squeeze shows up after dropping 2.68%
BCTX forms MACD Bullish Signal Line Cross on October 24
Is BCTX positioned for a breakout? Crossed Above 20 Day Moving Average shows up after surging 9.05%
Slingshot Bullish appears for BCTX after 5.64% move